NASDAQ : BFRI
Biofrontera Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.9315 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Biofrontera Inc. (BFRI) reported revenue of 46.17M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 46.17M | 41.70M | 37.32M | 34.07M | 28.67M | 24.10M |
| Cost of Revenue | 9.58M | 10.96M | 18.61M | 17.44M | 15.19M | 12.74M |
| Gross Profit | 36.59M | 30.74M | 18.71M | 16.63M | 13.49M | 11.36M |
| Selling, General & Admin | 39.78M | 38.37M | 33.84M | 37.90M | 35.00M | 25.96M |
| Research & Development | 2.99M | 3.72M | 2.09M | 77.00K | ||
| Operating Expenses | 42.77M | 42.09M | 35.92M | 37.98M | 35.00M | 25.96M |
| Operating Income | -6.17M | -11.35M | -17.21M | -21.35M | -21.51M | -14.60M |
| Interest Expense | -483.00K | -452.00K | -2.04M | -600.00K | -370.00K | -360.00K |
| Interest & Investment Income | 132.00K | 175.00K | 16.00K | |||
| Currency Exchange Gain (Loss) | -114.00K | -28.00K | ||||
| Other Non Operating Income (Expenses) | 11.00K | 587.00K | 1.84M | 3.04M | 16.36M | -12.65M |
| EBT Excluding Unusual Items | -6.64M | -11.21M | -17.41M | -18.89M | -5.38M | -27.60M |
| Merger & Restructuring Charges | -752.00K | |||||
| Gain (Loss) on Sale of Investments | -1.00K | 2.00K | -14.00K | -7.42M | 1.75M | |
| Gain (Loss) on Sale of Assets | 700.00K | 700.00K | ||||
| Legal Settlements | 6.16M | -870.00K | -11.25M | |||
| Other Unusual Items | -392.00K | -316.00K | 34.00K | 3.89M | 1.94M | |
| Pretax Income | -6.34M | -10.51M | -17.74M | -20.12M | -608.00K | -37.66M |
| Income Tax Expense | 29.00K | 25.00K | 22.00K | 14.00K | 32.00K | 56.00K |
| Net Income | -6.37M | -10.54M | -17.76M | -20.13M | -640.00K | -37.71M |
| Net Income to Common | -6.37M | -10.54M | -17.76M | -20.13M | -640.00K | -37.71M |
| Shares Outstanding (Basic) | 11.77M | 10.17M | 5.52M | 1.55M | 1.06M | 440.41K |
| Shares Outstanding (Diluted) | 11.77M | 10.17M | 5.52M | 1.55M | 1.06M | 440.41K |
| EPS (Basic) | -0.54 | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 |
| EPS (Diluted) | -0.54 | -1.04 | -3.22 | -13.02 | -0.61 | -85.63 |
| Free Cash Flow | -7.93M | -13.36M | -10.28M | -24.90M | -16.24M | -26.73M |
| Free Cash Flow Per Share | -0.67 | -1.31 | -1.86 | -16.10 | -15.36 | -60.68 |
| Gross Margin | 79.25% | 73.71% | 50.14% | 48.80% | 47.04% | 47.13% |
| Operating Margin | -13.36% | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% |
| Profit Margin | -13.79% | -25.26% | -47.58% | -59.09% | -2.23% | -156.49% |
| Free Cash Flow Margin | -17.17% | -32.04% | -27.54% | -73.08% | -56.63% | -110.90% |
| EBITDA | -5.97M | -11.21M | -16.79M | -20.85M | -20.99M | -14.06M |
| EBITDA Margin | -12.93% | -26.88% | -44.98% | -61.19% | -73.21% | -58.34% |
| D&A For EBITDA | 203.00K | 138.00K | 421.00K | 504.00K | 519.00K | 540.00K |
| EBIT | -6.17M | -11.35M | -17.21M | -21.35M | -21.51M | -14.60M |
| EBIT Margin | -13.36% | -27.21% | -46.11% | -62.67% | -75.02% | -60.59% |
| Revenue as Reported | 41.70M | 41.70M | 37.32M | 34.07M | 28.67M | 24.10M |
| Advertising Expenses | 200.00K | 100.00K | 500.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.66M | 6.39M | 5.91M | 1.34M | 17.21M | 24.55M |
| Short-Term Investments | 8.00K | 9.00K | 7.00K | 78.00K | 10.55M | |
| Cash & Short-Term Investments | 4.67M | 6.40M | 5.91M | 1.42M | 27.76M | 24.55M |
| Accounts Receivable | 5.54M | 7.29M | 5.32M | 5.16M | 3.75M | 3.78M |
| Other Receivables | 314.00K | 1.90M | 57.00K | 11.90M | ||
| Receivables | 5.86M | 9.20M | 5.37M | 5.16M | 3.75M | 15.69M |
| Inventory | 1.10M | 1.43M | 6.65M | 10.91M | 7.17M | 4.46M |
| Prepaid Expenses | 155.00K | 322.00K | 229.00K | 425.00K | 439.00K | 824.00K |
| Other Current Assets | 657.00K | 739.00K | 2.54M | 5.16M | 4.03M | 905.00K |
| Total Current Assets | 12.44M | 18.08M | 20.70M | 23.07M | 43.14M | 46.42M |
| Property, Plant & Equipment | 4.95M | 3.74M | 983.00K | 1.75M | 1.58M | 267.00K |
| Other Intangible Assets | 2.57M | 2.65M | 35.00K | 2.63M | 3.03M | 3.45M |
| Other Long-Term Assets | 4.11M | 4.09M | 383.00K | 482.00K | 3.13M | 3.08M |
| Total Assets | 24.06M | 28.56M | 22.10M | 27.93M | 50.88M | 53.22M |
| Accounts Payable | 5.36M | 6.67M | 7.20M | 8.91M | 2.39M | 740.00K |
| Accrued Expenses | 3.80M | 4.17M | 3.12M | 3.50M | 4.49M | 3.40M |
| Short-Term Debt | 3.90M | |||||
| Current Portion of Leases | 472.00K | 332.00K | 548.00K | 691.00K | 498.00K | |
| Other Current Liabilities | 914.00K | 730.00K | 1.16M | 1.09M | 13.52M | 9.70M |
| Total Current Liabilities | 10.54M | 11.89M | 12.02M | 18.09M | 20.89M | 13.84M |
| Long-Term Debt | 4.62M | 4.59M | 4.10M | |||
| Long-Term Leases | 2.41M | 1.24M | 276.00K | 804.00K | 848.00K | |
| Other Long-Term Liabilities | 535.00K | 360.00K | 1.27M | 4.25M | 5.26M | 28.05M |
| Total Liabilities | 18.11M | 18.08M | 17.67M | 23.14M | 27.01M | 41.88M |
| Common Stock | 14.00K | 12.00K | 9.00K | 2.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 139.24M | 138.41M | 121.83M | 104.44M | 103.40M | 90.22M |
| Retained Earnings | -133.30M | -127.94M | -117.41M | -99.65M | -79.52M | -78.88M |
| Shareholders' Equity | 5.96M | 10.48M | 4.43M | 4.79M | 23.88M | 11.34M |
| Total Liabilities & Equity | 24.06M | 28.56M | 22.10M | 27.93M | 50.88M | 53.22M |
| Total Debt | 7.50M | 6.16M | 4.92M | 5.40M | 1.35M | |
| Net Cash (Debt) | -2.84M | 240.00K | 990.00K | -3.98M | 26.41M | 24.55M |
| Net Cash Per Share | -0.24 | 0.02 | 0.18 | -2.57 | 24.99 | 55.73 |
| Filing Date Shares Outstanding | 14.85M | 11.65M | 8.87M | 5.09M | 1.37M | 855.24K |
| Total Common Shares Outstanding | 14.21M | 11.65M | 8.87M | 1.52M | 1.33M | 855.24K |
| Working Capital | 1.89M | 6.19M | 8.68M | 4.99M | 22.25M | 32.59M |
| Book Value Per Share | 0.42 | 0.90 | 0.50 | 3.16 | 17.89 | 13.26 |
| Tangible Book Value | 3.39M | 7.83M | 4.40M | 2.16M | 20.85M | 7.89M |
| Tangible Book Value Per Share | 0.24 | 0.67 | 0.50 | 1.43 | 15.62 | 9.22 |
| Machinery | 2.40M | 2.42M | 325.00K | 316.00K | 278.00K | |
| Leasehold Improvements | 7.00K | 368.00K | 368.00K | 368.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.37M | -10.54M | -17.76M | -20.13M | -640.00K | -37.71M |
| Depreciation & Amortization | 810.00K | 868.00K | 1.15M | 1.06M | 1.17M | 540.00K |
| Loss (Gain) From Sale of Assets | -700.00K | -700.00K | ||||
| Loss (Gain) From Sale of Investments | 1.00K | -2.00K | 14.00K | 7.42M | -1.75M | |
| Stock-Based Compensation | 1.13M | 951.00K | 1.02M | 1.04M | 1.85M | 129.00K |
| Provision & Write-off of Bad Debts | 28.00K | -69.00K | 162.00K | 122.00K | 106.00K | 44.00K |
| Other Operating Activities | 511.00K | -389.00K | -1.07M | -10.02M | -19.73M | 11.79M |
| Change in Accounts Receivable | -1.62M | -1.91M | -315.00K | -1.54M | -70.00K | -612.00K |
| Change in Inventory | -787.00K | 1.45M | 4.23M | -3.75M | -2.81M | 2.59M |
| Change in Accounts Payable | 474.00K | -535.00K | -1.81M | 6.42M | 912.00K | -773.00K |
| Change in Other Net Operating Assets | -1.41M | -2.49M | 4.10M | -5.52M | 4.76M | -2.71M |
| Operating Cash Flow | -7.93M | -13.36M | -10.27M | -24.89M | -16.20M | -26.71M |
| Capital Expenditures | -3.00K | -2.00K | -10.00K | -5.00K | -38.00K | -11.00K |
| Sale of Property, Plant & Equipment | 3.00M | 3.00M | ||||
| Sale (Purchase) of Intangibles | -50.00K | |||||
| Investment in Securities | 57.00K | 624.00K | -5.12M | |||
| Investing Cash Flow | 3.00M | 3.00M | -3.00K | 619.00K | -5.16M | -11.00K |
| Short-Term Debt Issued | 25.25M | |||||
| Long-Term Debt Issued | 4.05M | |||||
| Total Debt Issued | 4.05M | 25.25M | ||||
| Short-Term Debt Repaid | -4.32M | -21.34M | ||||
| Total Debt Repaid | -4.32M | -21.34M | ||||
| Net Debt Issued (Repaid) | -265.00K | 3.90M | ||||
| Issuance of Common Stock | 7.44M | 4.51M | 14.02M | 43.19M | ||
| Other Financing Activities | -8.50M | |||||
| Financing Cash Flow | 2.35M | 10.85M | 14.84M | 8.41M | 14.02M | 43.19M |
| Net Cash Flow | -2.58M | 487.00K | 4.56M | -15.87M | -7.33M | 16.46M |
| Free Cash Flow | -7.93M | -13.36M | -10.28M | -24.90M | -16.24M | -26.73M |
| Free Cash Flow Margin | -17.17% | -32.04% | -27.54% | -73.08% | -56.63% | -110.90% |
| Free Cash Flow Per Share | -0.67 | -1.31 | -1.86 | -16.10 | -15.36 | -60.68 |
| Levered Free Cash Flow | -7.60M | -2.36M | -5.07M | -24.79M | 2.36M | -9.66M |
| Unlevered Free Cash Flow | -7.30M | -2.08M | -3.80M | -24.41M | 2.59M | -9.43M |
| Cash Interest Paid | 3.00K | 6.00K | 1.73M | 147.00K | 1.00K | 2.00K |
| Cash Income Tax Paid | 25.00K | 25.00K | 24.00K | 15.00K | 32.00K | 56.00K |
| Change in Working Capital | -3.34M | -3.48M | 6.21M | -4.39M | 2.79M | -1.50M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 12.92M | 6.64M | 8.45M | 4.20M | 24.47M | 128.63M |
| Enterprise Value | 15.76M | 8.12M | 6.56M | 254.83K | -3.05M | 126.91M |
| Last Close Price | 0.87 | 0.57 | 1.09 | 2.77 | 18.33 | 150.40 |
| PS Ratio | 0.28 | 0.16 | 0.23 | 0.12 | 0.85 | 5.34 |
| PB Ratio | 2.08 | 0.63 | 1.91 | 0.88 | 1.02 | 11.35 |
| P/TBV Ratio | 3.81 | 0.85 | 1.92 | 1.94 | 1.17 | 16.31 |
| EV/Sales Ratio | 0.34 | 0.20 | 0.18 | 0.01 | 5.27 | |
| Debt / Equity Ratio | 1.26 | 0.59 | 1.11 | 1.13 | 0.06 | |
| Net Debt / Equity Ratio | 0.48 | -0.02 | -0.22 | 0.83 | -1.11 | -2.17 |
| Net Debt / EBITDA Ratio | -0.47 | 0.02 | 0.06 | -0.19 | 1.26 | 1.75 |
| Net Debt / FCF Ratio | -0.36 | 0.02 | 0.10 | -0.16 | 1.63 | 0.92 |
| Asset Turnover | 2.09 | 1.65 | 1.49 | 0.86 | 0.55 | 0.62 |
| Inventory Turnover | 3.74 | 2.72 | 2.12 | 1.93 | 2.61 | 2.21 |
| Quick Ratio | 1.00 | 1.31 | 0.94 | 0.36 | 1.51 | 2.91 |
| Current Ratio | 1.18 | 1.52 | 1.72 | 1.28 | 2.06 | 3.35 |
| Return on Equity (ROE) | -988.35% | -141.30% | -384.98% | -140.43% | -3.64% | -439.39% |
| Return on Assets (ROA) | -17.45% | -28.00% | -43.00% | -33.86% | -25.83% | -23.59% |
| Return on Capital Employed (ROCE) | -45.60% | -68.10% | -170.70% | -216.90% | -71.70% | -37.10% |
| Earnings Yield | -62.14% | -158.69% | -210.25% | -478.87% | -2.61% | -29.32% |
| FCF Yield | -61.36% | -201.26% | -121.70% | -592.32% | -66.35% | -20.78% |
| Buyback Yield / Dilution | -49.16% | -84.40% | -256.75% | -46.29% | -140.00% |